• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Monday, August 4, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

Swipha Bags WHO Product Prequalification

by Leadership News
12 months ago
in Business
swipha
Share on WhatsAppShare on FacebookShare on XTelegram

Pharmaceutical company Swiss Pharma Nigeria Limited (Swipha), has said it recorded another historic first and a significant milestone in its commitment to improving maternal health and combating malaria in Nigeria and beyond with the accomplishment of the World Health Organization (WHO) prequalification for its Sulfadoxine Plus Pyrimethamine (SP) 500/25mg Tablet for the prevention of malaria in pregnancy.

Advertisement

Disclosing this recently, the Managing Director of Swiss Pharma Nigeria Limited, Frederic Lieutaud, disclosed that the achievement of WHO Prequalification for Swipha’s SP 500/25mg Tablet underscores the company’s commitment to providing high-quality, life-saving medicines that meet international standards of safety, efficacy, and quality assurance. He noted that the prequalification also represents a significant step forward in the fight against malaria in pregnancy in Nigeria and across Africa.

“We are immensely proud to have received WHO Prequalification for our Sulfadoxine Plus Pyrimethamine Tablet for preventing malaria in pregnancy. This achievement demonstrates our unwavering commitment to improving maternal health and combating malaria, two critical public health challenges in Nigeria and beyond. We believe every woman deserves access to safe and effective preventive measures during pregnancy, and we are dedicated to making this a reality,” said Lieutaud.

Also speaking on the milestone, Swipha’s Business Development & Licensing Director Abbas Sambo stated that the achievement highlights Swipha’s belief in providing safe and effective medicines for all, particularly maternal and child health. “This certification enables us to offer the SP Tablet to organisations and governments worldwide, contributing to improved maternal and child health outcomes. We are actively seeking partnerships with global entities such as the Global Fund and USAID to tackle critical health challenges like Malaria,” Sambo added.

Sambo further stressed the importance of collaboration in addressing these health issues, reiterating Swipha’s commitment to working with global organisations, governments, and other stakeholders to ensure essential medicines are accessible to all.

RELATED

Mixed Performance On Equities Expected This Week

Earnings Optimism Triggers N4.32trn Equities Gain In 5 Days

26 minutes ago
Cadbury Nigeria Records N55bn Revenue In 2022

Cadbury Nigeria Records N14.54bn Pre-tax Profit In H1

28 minutes ago

“This achievement emphasises the incredible teamwork and support from its valued partners and supporters. Servier Generic Group, NAFDAC, Unitaid, Medicines for Malaria Venture (MMV), the World Health Organization (WHO), USAID, United States Pharmacopoeia (USP), and the USP-PQM+ program all played a crucial role in making this milestone possible. Their expertise and dedication were instrumental in this success, reflecting a shared commitment to improving health outcomes and increasing access to essential medicines. We appreciate all these partners for their vital contributions to this achievement and remain committed to innovation and excellence in pharmaceutical manufacturing, and will continue to pursue initiatives to improve public health in Nigeria and beyond”, he said.


We’ve got the edge. Get real-time reports, breaking scoops, and exclusive angles delivered straight to your phone. Don’t settle for stale news. Join LEADERSHIP NEWS on WhatsApp for 24/7 updates →

Join Our WhatsApp Channel




Tags: National Agency for Food and Drug Administration and Control (NAFDAC)Swiss Pharma Nigeria Limited (Swipha)USAIDWorld Health Organisation (WHO)
SendShareTweetShare
Previous Post

Immunisation: Social Behavioural Change Facilitators Meet In Kano

Next Post

Fixing Nigeria’s Housing Data Problem Our Top Priority – Minister

Leadership News

Leadership News

You May Like

Mixed Performance On Equities Expected This Week
Business

Earnings Optimism Triggers N4.32trn Equities Gain In 5 Days

2025/08/04
Cadbury Nigeria Records N55bn Revenue In 2022
Business

Cadbury Nigeria Records N14.54bn Pre-tax Profit In H1

2025/08/04
MTN Allots Incentive Shares, As Trading Opens With N4bn Loss
Business

MTNN Posts N414.9bn Profit After Tax In H1

2025/08/04
ASSBIFI Link Forex Rise On Unpatriotism Of Nigerians
Business

Despite Optimism, Forex Inflow Declines By 20.9% In July

2025/08/04
JUST-IN: Inflation In Nigeria Rises Further To 21.91%
Business

Easing Inflation, Currency Stability Prompted IMF’s Nigeria Growth Upgrade – Analysts

2025/08/04
swipha
Business

Consumers To Access N100m Mortgage Loans In FCMB

2025/08/04
Leadership Conference advertisement

LATEST

Ebonyi Community Cries Out Over Flooding

UNN Appoints Ortuanya 16th VC

Hunger: Stakeholders Seek Nutrition Units In MDAs, LGAs

Ex-Minister Opposes New State From Akwa Ibom

SDP Faults INEC’s Rejection Of Candidates In By-election

Opposition Will Collapse In Edo Before 2027 – Gov Okpebholo

Coalition Partners Must Unite To Strengthen ADC – Lukman

LG Poll: PDP Members Emerge APC Candidates In Rivers

Buni Upgrades CHC Gadaka To General Hospital As Yobe Absorbs 422 Health Workers

NJSC Dismisses A Magistrate, Two others

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.